PFG Advisors’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $5.3M | Buy |
14,633
+298
| +2% | +$102K | 0.27% | 84 |
|
|
2026
Q1 | $5.04M | Buy |
14,335
+948
| +7% | +$338K | 0.25% | 101 |
|
|
2025
Q4 | $4.38M | Sell |
13,387
-9,676
| -42% | -$3.07M | 0.21% | 108 |
|
|
2025
Q3 | $6.51M | Buy |
23,063
+1,588
| +7% | +$461K | 0.27% | 97 |
|
|
2025
Q2 | $6M | Buy |
21,475
+3,918
| +22% | +$1.11M | 0.28% | 75 |
|
|
2025
Q1 | $5.47M | Buy |
17,557
+4,769
| +37% | +$1.41M | 0.31% | 82 |
|
|
2024
Q4 | $3.33M | Sell |
12,788
-112
| -0.9% | -$33.2K | 0.2% | 117 |
|
|
2024
Q3 | $4.16M | Sell |
12,900
-1,056
| -8% | -$345K | 0.26% | 91 |
|
|
2024
Q2 | $4.36M | Buy |
13,956
+8
| +0.1% | +$2.35K | 0.29% | 79 |
|
|
2024
Q1 | $3.97M | Buy |
13,948
+44
| +0.3% | +$12.9K | 0.29% | 83 |
|
|
2023
Q4 | $4M | Sell |
13,904
-71
| -0.5% | -$19.3K | 0.32% | 78 |
|
|
2023
Q3 | $3.76M | Buy |
13,975
+269
| +2% | +$67.1K | 0.34% | 77 |
|
|
2023
Q2 | $3.04M | Buy |
13,706
+435
| +3% | +$101K | 0.23% | 107 |
|
|
2023
Q1 | $3.21M | Sell |
13,271
-149
| -1% | -$36.6K | 0.27% | 100 |
|
|
2022
Q4 | $3.52M | Buy |
13,420
+50
| +0.4% | +$13.4K | 0.35% | 69 |
|
|
2022
Q3 | $3.01M | Buy |
13,370
+197
| +1% | +$47.8K | 0.34% | 67 |
|
|
2022
Q2 | $3.21M | Sell |
13,173
-20
| -0.2% | -$4.9K | 0.36% | 55 |
|
|
2022
Q1 | $3.19M | Buy |
13,193
+668
| +5% | +$153K | 0.32% | 69 |
|
|
2021
Q4 | $2.82M | Buy |
12,525
+181
| +1% | +$38.2K | 0.28% | 98 |
|
|
2021
Q3 | $2.63M | Sell |
12,344
-482
| -4% | -$111K | 0.29% | 95 |
|
|
2021
Q2 | $3.13M | Buy |
12,826
+1,194
| +10% | +$294K | 0.36% | 67 |
|
|
2021
Q1 | $2.89M | Buy |
11,632
+343
| +3% | +$81.8K | 0.37% | 67 |
|
|
2020
Q4 | $2.6M | Buy |
11,289
+372
| +3% | +$85.8K | 0.44% | 62 |
|
|
2020
Q3 | $2.81M | Sell |
10,917
-190
| -2% | -$47.1K | 0.54% | 45 |
|
|
2020
Q2 | $2.77M | Sell |
11,107
-99
| -0.9% | -$22.6K | 0.62% | 37 |
|
|
2020
Q1 | $2.65M | Buy |
11,206
+957
| +9% | +$209K | 0.71% | 33 |
|
|
2019
Q4 | $2.44M | Sell |
10,249
-141
| -1% | -$31.1K | 0.6% | 42 |
|
|
2019
Q3 | $2.04M | Buy |
10,390
+1,089
| +12% | +$209K | 0.56% | 43 |
|
|
2019
Q2 | $1.63M | Buy |
9,301
+686
| +8% | +$123K | 0.44% | 56 |
|
|
2019
Q1 | $1.54M | Sell |
8,615
-8
| -0.1% | -$1.53K | 0.47% | 59 |
|
|
2018
Q4 | $1.63M | Buy |
+8,623
| New | +$1.68M | 0.51% | 53 |
|
Other funds holding AMGN
PFG Advisors's AMGN Position: Q2 2026 in Review
PFG Advisors increased its Amgen (AMGN) stake by 2.1% in Q2 2026, buying an estimated $102K and bringing the position to 14,633 shares worth $5.3M. The position accounts for 0.27% of the portfolio, ranked #84.
PFG Advisors first reported a position in AMGN in Q4 2018 and has held it in 31 quarters since. The position peaked at $6.51M in Q3 2025. 3,153 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- PFG Advisors held 14,633 shares of Amgen worth $5.3M as of Q2 2026.
- PFG Advisors bought 298 Amgen shares in Q2 2026, an estimated $102K.
- Amgen made up 0.27% of PFG Advisors's portfolio in Q2 2026, its #84 holding.
- PFG Advisors first reported a position in Amgen in Q4 2018 and has held it in 31 quarters since.
- PFG Advisors's Amgen position peaked at $6.51M in Q3 2025.
- 3,153 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on PFG Advisors's 13F filing for Q2 2026, filed 16 Jul 2026.